MedicineBiology
Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.
Hyun‐Jung Kim, S. Bae
tlooto Summary
Understanding of the molecular and biological events that underpin the anticancer effects of HDAC inhibitors and the outcomes of recent clinical trials involving these drugs are summarized.
Abstract
Abstract is not available.
Citation format
KIM, Hyun‐Jung; BAE, S. Histone deacetylase inhibitors: Molecular mechanisms of action and clinical trials as anti-cancer drugs. American Journal of Translational Research, 2011, 3 2: 166–79.